Not a single study
Story checked
Epstein-Barr virus activity may foreshadow multiple sclerosis attacks (opens in a new tab)
medicalxpress.com · 2026-09-16
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Epstein-Barr virus activity may foreshadow multiple sclerosis attacks
medicalxpress.com · 2026-09-16
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Source layer
The 2 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- Also referencedmentioned without context
10.1038/s41591-026-04665-3
- Also referencedpresented as the new finding
EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedA new study points to a causal role for reactivation of Epstein-Barr virus in triggering MS attacks in people with certain genetic risk factors.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedIn blood samples from more than 100 participants with MS, researchers detected increased EBV lytic activity in immune cells up to three months before MS relapse and elevated expression of genes linked to MS risk.View evidenceHide evidence
As statedup to three months before relapse
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedResearchers analyzed blood samples from 114 patients with MS and 21 healthy participants in the CLIMB study, using single-cell RNA sequencing and other molecular techniques to track immune changes before relapse.View evidenceHide evidence
As stated114 patients with MS and 21 healthy participants
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedB cells showed some of the strongest changes before relapse, including activation of genes associated with antiviral responses, inflammation and EBV activity, and an increase in ABC-like B cells.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedEBV proteins triggered MS risk genes to be expressed in immune cells before relapse, but not during remission or in healthy controls.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedThe authors say future studies are needed to determine whether the findings extend to early-stage and progressive forms of MS, and that larger prospective studies are needed before blood biomarkers could be used clinically.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome.
Brain : a Journal of Neurology · 2026 · PubMed, Europe PMC
Epstein Barr Virus and Blood Brain Barrier in Multiple Sclerosis
2013 · Crossref
Epstein-Barr virus and multiple sclerosis: Mechanisms, therapeutic implications, and emerging interventions.
Journal of Neuroimmunology · 2026 · PubMed, Europe PMC
Mechanisms of Epstein-Barr virus-associated autoimmunity: a comparative overview.
Frontiers in Immunology · 2026 · PubMed
Review for "The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases"
2022 · Crossref
And 10 more candidates considered.